Re: Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
I am grateful to Thomas Finnegan  for pointing out my error and the Pfizer trial had in fact included British participants. I am also pleased to know of his FOI requests to the MHRA, but he will perhaps be concerned to learn that the MHRA has failed to publish a single FOI response since the end of June . I have been in touch with them about this. Perhaps hundreds remain unpublished.
I am also concerned that that the MHRA licensed the trials for the Oxford/AZ product which included adenoviruses associated with blood clots and subsequently approved it as well as the similar Johnson & Johnson for roll-out [3,4]
 Thomas Finnegan, ‘ Re: Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial’, 24 November 2021, https://www.bmj.com/content/375/bmj.n2635/rr-60
 John Stone, ‘Re: Covid-19: Rare immune response may clause clots after AstraZeneca vaccine, say researchers’, 16 April 2021, https://www.bmj.com/content/373/bmj.n954/rr-2
 John Stone, ‘Had the MHRA done due diligence’, 21 April 2021, https://www.bmj.com/content/373/bmj.n961/rr-0
Competing interests: AgeofAutism.com, an on-line daily journal, concerns itself with the potential environmental sources for the proliferation of autism, neurological impairment, immune dysfunction and chronic disease. I receive no payment as UK Editor. I also moderate comments for the on-line journal ‘The Defender’ for which I am paid. I am also a member of the UK Medical Freedom Alliance